PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers.

PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers. — المؤلف: Bonazzoli, Elena — Gynecologic oncology 20190513

المؤلف
Bonazzoli, Elena
النشر
Gynecologic oncology 20190513
الوصف
158-164 p.
الموضوعات
Adult؛ Afatinib؛ Aged؛ Animals؛ Antineoplastic Agents؛ Cell Line, Tumor؛ Class I Phosphatidylinositol 3-Kinases؛ Class Ia Phosphatidylinositol 3-Kinase